We are committed to delivering unparalleled scientific excellence and to providing cutting-edge raw materials for impactful IVD solutions that save lives.
We are renowned for uncompromised quality that extends from product development to safe and secure deliveries worldwide. Continuous investment in scientific research forms a solid foundation for our product development, and our ISO9001 certified operations ensure that our products meet the highest levels of quality that you expect.
We have compiled our products, technical capabilities and story into a brochure. Please download it here and read more.
Netta is the CEO at HyTest. She joined the company in 2013 as a Business Development Manager and before stepping into the current role she worked as the Sales and Marketing Director of HyTest. Before HyTest, Netta worked in various Marketing related positions at Finnzymes and Thermo Fisher Scientific, latest as a Senior Product Marketing Manager at Thermo Scientific.
Netta holds a PhD in Biochemistry from the University of Helsinki and an MBA from Warwick Business School
Michael is the Chief Financial Officer at HyTest. Prior to joining HyTest Michael worked in lead financial positions of companies in different industries (production, contracting and maintenance services, food supply) and has broad finance and accounting experience at a group level.
Michael holds an MSc from the Helsinki School of Economics.
Soozy is the CCO of Hytest and worked as the General Manager of HyTest Bio-Tech (Shanghai, China) 2011-2023. Prior to joining the company in 2011 she held various different positions at Yarewell and Genetimes. Soozy holds a BSc in Biotechnology from Zhejiang University and an MBA from Shanghai Jiaotong University. |
Alexey has been the R&D Director at HyTest Ltd. since 1994. He is also a professor at the Department of Biochemistry at the Lomonosov Moscow State University. Alexey has been studying cardiac markers since the beginning of the 1990s and together with his team at HyTest has been regularly publishing articles in peer reviewed journals. Alexey is a member of two IFCC SD Working Groups: “Standardization of Troponin I (WG-TNI)” and “Standardization of Pregnancy-Associated Plasma Protein A (WG-PAPPA)”.
Alexey holds a PhD in Biochemistry.
Grigory is the Production Director at HyTest. He joined the company in 2022 as Deputy of Production Director. Before HyTest, Grigory worked in various Biotechnology related positions at JSC Pharmasyntez and Endopharm. During studies in the Ph.D. program, he carried out joint research project with NIH and Montana State University.
Grigory holds Ph.D in Immunology and Allergology from the Institute of Immunology.
Sakke is the Quality Director at HyTest. She joined the company in 2002 and is responsible for overseeing all regulatory and quality related issues. Prior to joining HyTest, she worked as a Research Assistant at the All Russian Research Institute of Phytopathology.
Sakke holds a BSc in Biotechnology from the Turku University of Applied Sciences
Yulia is the General Director of HyTest Russia, which is a fully owned subsidiary of HyTest Ltd and was established in 2016. Yulia joined the company in 1996. Prior to the establishment of HyTest Russia, Yulia was the General Director of Bialexa Ltd. She has also been a Senior Scientist and Project Manager at the Moscow Institute of Medical Ecology.
Yulia holds a PhD in Biochemistry from Lomonosov Moscow State University.
Copyright © 2025 Hytest Ltd.
